Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

86.11

+1.45 (1.71%)

At close: Dec 5, 2025, 4:00 PM EST

87.73

+1.63 (1.89%)

After-hours: Dec 5, 2025, 7:59 PM EST

Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $9.06 billion as of December 5, 2025. Its market cap has increased by 64.28% in one year.

Market Cap

9.06B

Enterprise Value

8.54B

1-Year Change

64.28%

Ranking

#967

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $9.06B, an increase of 3,100.44%. That is a compound annual growth rate of 17.36%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	8.91B	68.67%
Dec 31, 2024	5.28B	57.69%
Dec 29, 2023	3.35B	53.13%
Dec 30, 2022	2.19B	-4.35%
Dec 31, 2021	2.29B	-24.78%
Dec 31, 2020	3.04B	119.78%
Dec 31, 2019	1.38B	-10.36%
Dec 31, 2018	1.54B	-25.15%
Dec 29, 2017	2.06B	155.69%
Dec 30, 2016	806.10M	48.81%
Dec 31, 2015	541.70M	78.43%
Dec 31, 2014	303.60M	-5.24%
Dec 31, 2013	320.40M	124.53%
Dec 31, 2012	142.70M	-50.47%
Dec 30, 2011	288.10M	3.11%
Dec 31, 2010	279.40M	60.85%
Dec 31, 2009	173.70M	248.10%
Dec 31, 2008	49.90M	-59.17%
Dec 31, 2007	122.20M	336.43%
Dec 29, 2006	28.00M	-66.22%
Dec 30, 2005	82.90M	-41.54%
Dec 31, 2004	141.80M	-49.89%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	905.04B
Johnson & Johnson	488.68B
AbbVie	404.64B
UnitedHealth Group	303.12B
AstraZeneca	283.29B
Novartis AG	257.47B
Merck & Co.	252.30B
Abbott Laboratories	215.95B

Market Cap Rankings